Showing results (511-520 of 1,193) with videos related to

Sort By:
Pageof 120
Leukemia|April 1, 1989
Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemiaE Estey, T L Smith, M J Keating, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1987
Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2E Lotzová, C A Savary, R B Herberman, et al.
Cancer|April 11, 1975
Long-term second remissions in acute lymphatic leukemiaB G Leventhal, A S Levine, R G Graw, et al.
Leukemia Research|January 1, 1991
Highly oncolytic adherent lymphocytes: therapeutic relevance for leukemiaE Lotzová, C A Savary, K Totpal, et al.
American Journal of Clinical Oncology|August 1, 1984
Phase II evaluation of PALA in patients with refractory metastatic sarcomasR Kurzrock, B S Yap, C Plager, et al.
Cancer|January 1, 1984
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancerA Aboud, H Y Yap, L Esparza, et al.
The Journal of Infectious Diseases|July 1, 1991
Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonizationN Khardori, E Wong, H Nguyen, et al.
Cancer Treatment Reports|September 1, 1981
Chemotherapy for colorectal cancer with a combination of PALA and 5-FUA Y Bedikian, J R Stroehlein, D A Karlin, et al.
Cancer Treatment Reports|September 1, 1981
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusionH Y Yap, G R Blumenschein, G P Bodey, et al.
Annals of Internal Medicine|December 1, 1981
Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancerH Y Yap, G R Blumenschein, F C Schell, et al.
Pageof 120